EARNING RECAP

Netflix Inc

#NFLX 2019 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q2 60c est. 56c $4.92B est. $4.93B -10.27% ($325.21 closing price) $329.85 $320.30 sees Q3 EPS $1.04, consensus $1.04 Sees Q3 revenue $5.25B, est. $5.25B;sees Q3 streaming paid net additons of 7.0M
Q1 76c est. 57c $4.52B est. $4.5B -1.31% ($354.74 closing price) $368.76 $350.60 Q1 streaming paid net additions of 9.6M; see Q2 net additions of 5M; sees Q2 ARPU +2% vs: -2% & total revenue growth +26% vs: 22% in Q1; FY19 operating margin target unchanged at 13%
#NFLX 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 56c est. 83c $4.19B est. $4.21B -3.99% ($339.10 closing price) $353 $336.73
Q3 89c vs 68c $4.0B est. $4.0B +5.28% ($364.70 closing) $380.00 $356.50 US memberships added by 1.09M and International added 5.87 million membership.
Q2 85c est. 79c $3.91B est. $3.94B -5.24% ($379.48 closing) $385 $344 Q3 subscribers addition of 5M - 650K in U.S. 4.35M International
Q1 64c est. 64c $3.7B est. $3.69 +9.19% ($336.06 closing) $338.62 $323.77 Q1 net additions of 7.4M members; Guides Q2 62.M members additions
#NFLX 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 41c vs 41c $3.29B vs $3.28B +9.98% ($250.29 closing) $257.71 $248.02 Streaming net additions of 8.33M members.Market cap hits $100 billion for first time in extended trade. +9.55% to $249.38
Q3 29c Vs 32c $2.99B Vs $2.97B -1.58% ($199.08 closing) $204.38 $197.77 International streaming adds 4.45m vs 3.72m estimate. Stock popped after hours to $210 highs, but sell off next opening bell at $200 level.
Q2 15C VS 16c est $2.785B vs 2.76B +13.54% ($183.60 closing) $185.00 $174.24 +10.69% at $178.98 ah.. Streaming additions of 5.2 members
Q1 0.40c vs 0.37c est. $2.64B vs $2.65B est. -2.64%. ($143.36 closing) $147.40 $140.00 Opened near highs, but faded throughout the day. Intl’s streaming adds $3.53M vs $3.90M est

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.